US Stocks - Insider Trading disclosures made on Mar 31, 2025

Advanced/Help

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Showing you 400 results sorted by most recent dates. Subscribe to see a larger data set

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Stagwell Inc - Ordinary Sh...	Mark Penn J.	Director, Chief Executive Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	151,648,741	151,778,741	-		-	Class A Common Stock
Stagwell Inc - Ordinary Sh...	Mark Penn J.	Director, Chief Executive Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	151,648,741	0	-		-	Class C Common Stock
UWM Holdings Corporation -...	Mathew Ishbia	Director, President and CEO, Ten Percent Owner		31 Mar 2025	13,028,909	13,028,909	-		-	Class A Common Stock
UWM Holdings Corporation -...	Mathew Ishbia	Director, President and CEO, Ten Percent Owner		31 Mar 2025	13,028,909	1,397,782,620	-		-	UWM Paired Interests
UWM Holdings Corporation -...	Mathew Ishbia	Director, President and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 0.00 per share.	31 Mar 2025	13,028,909	0	-		-	Class A Common Stock
SS Innovations Internation...	Sudhir Srivastava	Director, Chairman and CEO, Ten Percent Owner		31 Mar 2025	5,811,554	112,926,514	-	1.4	8,019,945	Common Stock, $0.0001 par value
Mawson Infrastructure Grou...	Rahul Mewawalla	Director, Director, CEO, President, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	1,587,302	3,496,194	-		-	Common Stock
Mawson Infrastructure Grou...	Rahul Mewawalla	Director, Director, CEO, President, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	1,587,302	0	-		-	Restricted Stock Units
Intuitive Machines Inc - O...	Kamal Seyed Ghaffarian	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	31 Mar 2025	1,292,729	36,496,032	-		-	Common Units
Intuitive Machines Inc - O...	Kamal Seyed Ghaffarian	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	31 Mar 2025	1,292,729	36,496,032	-		-	Class C Common Stock
Crowdstrike Holdings Inc -... 5-year high	George R. Kurtz	Director, PRESIDENT AND CEO	Gift of securities by or to the insider at price $ 0.00 per share.	31 Mar 2025	1,246,087	0 (0%)	3%		0	Class A common stock
Oncology Institute Inc (The)	Daniel Virnich	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	1,083,334	1,807,697	-		0	Common stock
Organon & Co.	Kevin Ali	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	1,072,607	1,072,607	-		-	Stock Option (right to buy)
Crowdstrike Holdings Inc -... 5-year high	George R. Kurtz	Director, PRESIDENT AND CEO	Gift of securities by or to the insider at price $ 0.00 per share.	31 Mar 2025	1,021,038	0 (0%)	2%		0	Class A common stock
Crowdstrike Holdings Inc -... 5-year high	George R. Kurtz	Director, PRESIDENT AND CEO	Gift of securities by or to the insider at price $ 0.00 per share.	31 Mar 2025	940,788	0 (0%)	2%		0	Class A common stock
Pyxis Oncology Inc	Lara S. Sullivan	Director, President ,CEO & CMO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	918,308	918,308	-		-	Stock Option (Right to Buy)
Arbutus Biopharma Corp	Tuan Nguyen	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	750,000	750,000	-		-	Stock Option (Right to Buy)
Arbutus Biopharma Corp	Tuan Nguyen	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	750,000	750,000	-		-	Stock Option (Right to Buy)
First Horizon Corporation	D. Bryan Jordan	Director, Chairman, President & CEO	Gift of securities by or to the insider at price $ 0.00 per share.	31 Mar 2025	725,848	1,197,797 (0%)	0%		0	Common Stock
Mawson Infrastructure Grou...	Rahul Mewawalla	Director, Director, CEO, President, Ten Percent Owner	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.50 per share.	31 Mar 2025	633,713	2,862,481	-	0.5	316,857	Common Stock
ADT Inc	Donald M. Young	EVP & COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	614,637	2,947,342 (0%)	0%		0	Common Stock
Ryerson Holding Corp.	Edward J. Lehner	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	600,000	600,000	-		-	Restricted Stock Units
Exelixis Inc Board Meeting	Michael M. Morrissey	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	589,719	1,623,009 (0%)	0%		0	Common Stock
ADT Inc	Jeff Likosar	Pres Corp Dev & Trans. & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	573,387	1,698,218 (0%)	0%		0	Common Stock
ADT Inc	Jeff Likosar	Pres Corp Dev & Trans. & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	573,387	1,263,781 (0%)	0%		0	Common Stock
ADT Inc	James D. DeVries	Director, Chairman, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	559,597	3,565,937 (0%)	0%		0	Common Stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Jonathan Maurer	Co-Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	489,429	489,429	-		-	Restricted Stock Units
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Adam Comora	Co-Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	489,429	489,429	-		-	Restricted Stock Units
Local Bounti Corp - Ordina...	Charles R. Schwab	Director	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	31 Mar 2025	429,137	429,137	-		-	Series A Convertible Preferred Stock
Pyxis Oncology Inc	Pamela Yanchik Connealy	CFO & COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	414,163	414,163	-		-	Stock Option (Right to Buy)
Stardust Power Inc.	Chris Celano	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	408,719	408,719	-		0	Common Stock
ADT Inc	Jeff Likosar	Pres Corp Dev & Trans. & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	397,410	1,720,945	-		-	Employee Stock Option (right to buy)
ADT Inc	Jeff Likosar	Pres Corp Dev & Trans. & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	397,410	1,720,945	-		-	Employee Stock Option (right to buy)
ADT Inc	James D. DeVries	Director, Chairman, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	387,853	1,840,278	-		-	Employee Stock Option (right to buy)
C3.ai Inc - Ordinary Share... Board Meeting High Gain High Volume	James Hageman Snabe	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	360,000	370,000	-		0	Class A Common Stock
ADT Inc	Donald M. Young	EVP & COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	356,160	1,503,420	-		-	Employee Stock Option (right to buy)
Starwood Property Trust Inc	Barry S. Sternlicht	Director, CEO, Chairman of the Board	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	345,833	2,245,835	-		-	Restricted Stock Units
Starwood Property Trust Inc	Barry S. Sternlicht	Director, CEO, Chairman of the Board	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	345,833	2,880,440 (1%)	0%		-	Common Stock
Organon & Co.	Matthew M. Walsh	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	317,656	317,656	-		-	Stock Option (right to buy)
Healthcare Triangle Inc 52 week low	Lakshmanan Kannappan	Business Head	Other type of transaction at price $ 0.00 per share.	31 Mar 2025	304,180	324,180	-		0	Common Stock
StoneX Group Inc	Sean M. O'Connor	Director, Executive Vice-Chairman-Board	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	300,000	1,057,167 (5%)	1%		0	Restricted Shares of Common Stock
Hyperfine Inc - Ordinary S... High Gain High Volume	Thomas Teisseyre	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	300,000	382,213	-		0	Class A Common Stock
Hyperfine Inc - Ordinary S... High Gain High Volume	Brett Hale	CFO and CAO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	300,000	300,000	-		0	Class A Common Stock
CERo Therapeutics Holdings...	Brian G. Atwood	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	294,460	11,660	-		-	Pre-Funded Warrant
CERo Therapeutics Holdings...	Brian G. Atwood	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	294,460	490,534	-	0.0	29	Common Stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Kazi Hasan	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	293,657	293,657	-		-	Restricted Stock Units
Charles Schwab Corp.	Todd M. Ricketts	Director	Gift of securities by or to the insider at price $ 0.00 per share.	31 Mar 2025	290,608	525,805 (0%)	0%		0	Common Stock
Cidara Therapeutics Inc	Jeffrey Stein	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	275,000	275,000	-		-	Employee Stock Option (right to buy)
Ouster Inc - Ordinary Shar...	Angus Pacala	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	275,000	1,044,957	-		0	Common Stock
Atlas Lithium Corporation Board Meeting	Marc Fogassa	Director, Chief Executive Officer, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	265,153	4,983,231	-		0	Common Stock
Pyxis Oncology Inc	Jitendra Wadhane	SVP, Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	263,782	263,782	-		-	Stock Option (Right to Buy)
Organon & Co.	Joseph T. Morrissey	Head of Manufacturing	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	247,524	247,524	-		-	Stock Option (right to buy)
AudioEye Inc	David Moradi	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	241,444	1,105,867 (12%)	2%		0	Common Stock
Abercrombie & Fitch Co. - ... Board Meeting High Gain High Volume	Fran Horowitz-Bonadies	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	230,096	811,703 (1%)	0%		0	Class A Common Stock
Clear Channel Outdoor Hold... Board Meeting	Justin Cochrane	Former CEO, UK & Europe	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	221,759	1,191,623 (2%)	0%		0	Common Stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Kazi Hasan	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	220,243	220,243	-		-	Restricted Stock Units
Organon & Co.	Kevin Ali	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	218,267	218,267	-		-	Restricted Stock Units
Dyne Therapeutics Inc Board Meeting	Erick J. Lucera	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	214,500	214,500	-		-	Stock Option (Right to Buy)
Organon & Co.	Juan Camilo Arjona Ferreira	Head of R&D & CMO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	198,019	198,019	-		-	Stock Option (right to buy)
Oncology Institute Inc (The)	Robert Ross Carter	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	197,368	236,775	-		0	Class A Common Stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	John Coghlin	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	195,772	195,772	-		-	Restricted Stock Units
Hallador Energy Co Board Meeting	Brent K. Bilsland	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.28 per share.	31 Mar 2025	194,258	1,143,235 (3%)	0%	12.3	2,385,488	COMMON STOCK
Stagwell Inc - Ordinary Sh...	Mark Penn J.	Director, Chief Executive Officer, Ten Percent Owner	Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.93 per share.	31 Mar 2025	191,354	2,367,654	-	5.9	1,134,729	Class A Common Stock
Organon & Co.	Rachel A. Stahler	Chief Information Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	181,518	181,518	-		-	Stock Option (right to buy)
Organon & Co.	Kirke Weaver	Gen. Counsel & Corp. Secy.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	181,518	181,518	-		-	Stock Option (right to buy)
Commercial Vehicle Group Inc	Chung Kin Cheung	EVP & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	181,132	316,352 (1%)	0%		0	Common Stock, $0.01 par value
Macy`s Inc Board Meeting	Adrian V. Mitchell	EVP, COO & CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	171,526	0	-		-	Restricted Stock Units
Macy`s Inc Board Meeting	Adrian V. Mitchell	EVP, COO & CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	171,526	337,834 (0%)	0%		0	Common Stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	David Unger	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	171,300	171,300	-		-	Restricted Stock Units
Exelixis Inc Board Meeting	Christopher J. Senner	EVP and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	170,009	1,009,264 (0%)	0%		0	Common Stock
SS Innovations Internation...	Sudhir Srivastava	Director, Chairman and CEO, Ten Percent Owner	Gift of securities by or to the insider at price $ 0.00 per share.	31 Mar 2025	165,000	112,761,514	-		0	Common Stock, $0.0001 par value
TJX Companies, Inc.	Ernie L. Herrman	Director, CEO & President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	164,450	630,639 (0%)	0%		0	Common Stock
Oncology Institute Inc (The)	Jeremy N Castle	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	162,281	252,667	-		0	Common stock
Corcept Therapeutics Inc	Joseph Douglas Lyon	See Remarks	Sale of securities on an exchange or to another person at price $ 100.22 per share.	31 Mar 2025	162,008	47,001 (0%)	0%	100.2	16,236,571	Common Stock
Exelixis Inc Board Meeting	Amy C. Peterson	EVP Prod Dev & Med Aff & CMO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	159,383	506,472 (0%)	0%		0	Common Stock
Exelixis Inc Board Meeting	Patrick J. Haley	EVP, Commercial	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	159,383	500,411 (0%)	0%		0	Common Stock
Oncology Institute Inc (The)	Yale Podnos	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	157,088	236,137	-		0	Common stock
Alto Ingredients Inc	Bryon T. McGregor	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	155,500	989,765 (1%)	0%		0	Common Stock
Exelixis Inc Board Meeting	Jeffrey J. Hessekiel	EVP & General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	154,070	751,678 (0%)	0%		0	Common Stock
Savara Inc 52 week low High Loss High Volume	David A. Ramsay	Director	Purchase of securities on an exchange or from another person at price $ 2.78 per share.	31 Mar 2025	150,000	2,513,642 (4%)	0%	2.8	416,250	Common Stock
FitLife Brands Inc	Dayton Judd	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.62 per share.	31 Mar 2025	144,000	1,031,226	-	2.6	377,280	Common Stock
FitLife Brands Inc	Dayton Judd	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	144,000	0	-		-	Stock Options
Ardent Health Partners Inc Board Meeting	Martin J. Bonick	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	134,927	1,126,984	-		0	Common Stock
Exelixis Inc Board Meeting	Dana T. Aftab	CSO/EVP Disc & Trans Research	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	132,819	693,936 (0%)	0%		0	Common Stock
FrontView REIT Inc. Board Meeting	Randall Starr	Director, Co-CEO and Co-President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	130,500	130,500	-		-	Restricted Stock Units
Timken Co.	Richard Kyle	Director, Interim President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	126,700	286,963 (0%)	0%		0	Common Stock
Organon & Co.	Vittorio Nisita	Head of Global Business Svcs	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	123,762	123,762	-		-	Stock Option (right to buy)
AT&T, Inc.	Pascal Desroches	Sr. Exec VP and CFO	Grant, award, or other acquisition of securities at price $ 28.28 per share.	31 Mar 2025	118,119	121,297 (0%)	0%	28.3	3,340,417	Common Stock
Cipher Mining Inc	Tyler Page	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	113,225	5,530,662	-		-	Common Stock
Cipher Mining Inc	Tyler Page	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	113,225	5,213,601	-		-	Restricted Stock Units
Kohl`s Corp. Board Meeting	Nicholas David George Jones	Chief Merchandising Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	112,469	171,904 (0%)	0%		-	Common Stock
Kohl`s Corp. Board Meeting	Jill Timm	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	112,469	360,309 (0%)	0%		-	Common Stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Darrell Birck	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	110,122	110,122	-		-	Restricted Stock Units
Stagwell Inc - Ordinary Sh...	Mark Penn J.	Director, Chief Executive Officer, Ten Percent Owner	Sale or transfer of securities back to the company at price $ 0.00 per share.	31 Mar 2025	106,746	2,559,008	-		0	Class A Common Stock
Clear Channel Outdoor Hold... Board Meeting	Justin Cochrane	Former CEO, UK & Europe	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.11 per share.	31 Mar 2025	105,703	969,864 (1%)	0%	1.1	117,330	Common Stock
Hallador Energy Co Board Meeting	Brent K. Bilsland	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	105,079	210,157	-		-	RSU
Clear Channel Outdoor Hold... Board Meeting	Justin Cochrane	Former CEO, UK & Europe	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.11 per share.	31 Mar 2025	104,782	1,086,841 (2%)	0%	1.1	116,308	Common Stock
Abercrombie & Fitch Co. - ... Board Meeting High Gain High Volume	Fran Horowitz-Bonadies	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.37 per share.	31 Mar 2025	103,200	708,503 (1%)	0%	76.4	7,881,384	Class A Common Stock
Macy`s Inc Board Meeting	Adrian V. Mitchell	EVP, COO & CFO	Sale of securities on an exchange or to another person at price $ 12.88 per share.	31 Mar 2025	101,633	236,201 (0%)	0%	12.9	1,309,033	Common Stock
Silence Therapeutics Plc -...	Richard Ian Griffiths	Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	31 Mar 2025	100,000	9,861,299	-		-	American Depositary Shares
Corcept Therapeutics Inc	Sean Maduck	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.27 per share.	31 Mar 2025	100,000	185,622 (0%)	0%	8.3	827,000	Common Stock
Corcept Therapeutics Inc	Sean Maduck	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	100,000	300,000	-		-	Stock option (right to buy)
Organon & Co.	Daniel Karp	Executive VP, Corp. Dev.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	99,009	99,009	-		-	Stock Option (right to buy)
Hallador Energy Co Board Meeting	Heath Aaron Lovell	President-Hallador Power	Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.28 per share.	31 Mar 2025	98,835	166,867 (0%)	0%	12.3	1,213,694	COMMON STOCK
First Guaranty Bancshares Inc	William K. Hood	Director	Purchase of securities on an exchange or from another person at price $ 8.47 per share.	31 Mar 2025	98,460	98,460 (1%)	1%	8.5	833,956	COMMON STOCK
Palantir Technologies Inc ...	Ryan Taylor	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	98,177	32,307	-		-	Class B Common Stock
Palantir Technologies Inc ...	Ryan Taylor	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	98,177	501,348	-		-	Class A Common Stock
Kohl`s Corp. Board Meeting	Fred Hand	SEVP, Director of Stores	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	97,800	257,453 (0%)	0%		-	Common Stock
Commercial Vehicle Group Inc	Aneezal H. Mohamed	Chief Legal Ofc, Cmp Ofc & Sec	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	96,855	271,475 (0%)	0%		0	Common Stock, $0.01 par value
Procore Technologies Inc	Craig F. Courtemanche	Director, CEO & President, Chairman of the Board	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	93,437	815,616	-		0	Common Stock
Hallador Energy Co Board Meeting	Brent K. Bilsland	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	89,179	0	-		-	Restricted Stock Unit
Commercial Vehicle Group Inc	Kristin S Mathers	Chief HR Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	86,038	161,269 (0%)	0%		0	Common Stock, $0.01 par value
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Scott Edelbach	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	85,650	85,650	-		-	Restricted Stock Units
Frontdoor Inc.	William C. Cobb	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	84,144	84,144	-		-	Restricted Stock Units
OPAL Fuels Inc - Ordinary ... High Gain High Volume	David Unger	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	80,704	138,026	-		-	Class A common stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	David Unger	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	80,704	80,703	-		-	Restricted Stock Units
Purple Innovation Inc - Or...	Robert T. DeMartini	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	80,386	902,746 (4%)	0%		-	Class A Common Stock
Purple Innovation Inc - Or...	Robert T. DeMartini	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	80,386	160,771	-		-	Restricted Stock Units
TJX Companies, Inc.	Ernie L. Herrman	Director, CEO & President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.80 per share.	31 Mar 2025	79,512	551,127 (0%)	0%	121.8	9,684,562	Common Stock
Corcept Therapeutics Inc	Sean Maduck	See Remarks	Sale of securities on an exchange or to another person at price $ 100.26 per share.	31 Mar 2025	79,277	106,345 (0%)	0%	100.3	7,947,995	Common Stock
Climb Bio Inc.	Douglas E. Williams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	78,873	78,873	-		-	Stock Option (Right to Buy)
Techprecision Corp	Phillip E. Podgorski	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	78,261	78,261	-		0	Common Stock
National Vision Holdings Inc	Christopher Laden	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	78,248	78,248	-		-	Restricted Stock Units
National Cinemedia Inc	Thomas F. Lesinski	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	77,500	0	-		-	Restricted Stock Units
National Cinemedia Inc	Thomas F. Lesinski	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	77,500	407,041 (0%)	0%		0	Common Stock
Beam Therapeutics Inc	John Evans	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	77,500	1,016,159 (2%)	0%		0	Common Stock
Maiden Holdings Ltd High Gain High Volume	William T. Jarman	SVP & Chief Actuary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	76,086	238,341 (0%)	0%		0	Common Shares
TJX Companies, Inc.	Carol Meyrowitz	Director, Executive Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	75,437	245,084 (0%)	0%		0	Common Stock
Corcept Therapeutics Inc	Joseph Douglas Lyon	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	75,000	0	-		-	Stock option (right to buy)
Corcept Therapeutics Inc	Joseph Douglas Lyon	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.52 per share.	31 Mar 2025	75,000	119,009 (0%)	0%	16.5	1,239,000	Common Stock
LifeMD Inc 52 week high	Nicholas Alvarez	Chief Acquisition Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	75,000	580,000	-		0	Common Shares
LifeMD Inc 52 week high	Marc David Benathen	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	75,000	464,554	-		0	Common Stock
Ryerson Holding Corp.	Edward J. Lehner	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	73,700	705,369 (1%)	0%		0	Common Stock (par value $0.01 per share)
Core & Main Inc - Ordinary...	Mark R. Witkowski	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	73,458	73,458	-		-	Options (Rights to Buy)
Kohl`s Corp. Board Meeting	Jennifer J. Kent	Sr.EVP & CLO & Corp. Sec.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	73,350	203,825 (0%)	0%		-	Common Stock
Kohl`s Corp. Board Meeting	Christie Raymond	Sr. EVP & Chief Marketing Off.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	73,350	256,701 (0%)	0%		-	Common Stock
Local Bounti Corp - Ordina...	Charles R. Schwab	Director	Purchase of securities on an exchange or from another person at price $ 2.00 per share.	31 Mar 2025	70,863	70,863	-	2	141,726	Common Stock
Procore Technologies Inc	Steven Scott Davis	PRESIDENT PRODUCT & TECHNOLOGY	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	68,281	225,074	-		0	Common Stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Jonathan Maurer	Co-Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	67,205	175,943	-		-	Class A common stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Jonathan Maurer	Co-Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	67,205	134,408	-		-	Restricted Stock Units
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Adam Comora	Co-Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	67,205	160,918	-		-	Class A common stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Adam Comora	Co-Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	67,205	134,408	-		-	Restricted Stock Units
British American Tobacco P... 52 week high	Tadeu Marroco	Executive Director,Chief Executive Officer		31 Mar 2025	67,109	214,067 (0%)	0%		0	Ords 0.25p
Stagwell Inc - Ordinary Sh...	Frank P. Lanuto	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.93 per share.	31 Mar 2025	66,948	594,328	-	5.9	397,002	Class A Common Stock
Dyne Therapeutics Inc Board Meeting	Erick J. Lucera	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	66,100	66,100	-		0	Common Stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Betsy L. Battle	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	66,073	66,073	-		-	Restricted Stock Units
OPAL Fuels Inc - Ordinary ... High Gain High Volume	James J. Martell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	66,073	66,073	-		-	Restricted Stock Units
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Ashok Vemuri	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	66,073	66,073	-		-	Restricted Stock Units
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Kevin M. Fogarty	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	66,073	66,073	-		-	Restricted Stock Units
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Scott Dols	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	66,073	66,073	-		-	Restricted Stock Units
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Mark S. Comora	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	66,073	66,073	-		-	Restricted Stock Units
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Nadeem Nisar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	66,073	66,073	-		-	Restricted Stock Units
Maiden Holdings Ltd High Gain High Volume	Mark O. Heintzman	Senior Vice President Finance	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	65,217	104,432 (0%)	0%		0	Common Shares
Procore Technologies Inc	Howard Fu	CFO & Treasurer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	64,687	209,400	-		0	Common Stock
Organon & Co.	Matthew M. Walsh	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	64,640	64,640	-		-	Restricted Stock Units
Lulus Fashion Lounge Holdi...	Crystal Landsem	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.40 per share.	31 Mar 2025	63,456	1,992,423	-	0.4	25,382	Common Stock
Omega Healthcare Investors...	C. Taylor Pickett	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	62,623	572,046	-		-	Profits Interest Units
Omega Healthcare Investors...	C. Taylor Pickett	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	62,623	888,588	-		-	OP Units
Carvana Co. - Ordinary Sha... 52 week high	Benjamin Huston	Chief Operating Officer		31 Mar 2025	62,500	91,449	-		-	Class B Units
RAPT Therapeutics Inc Board Meeting High Loss High Volume	Mary Ann Gray	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	61,202	61,202	-		-	Director Stock Option (right to buy)
Omega Healthcare Investors...	C. Taylor Pickett	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	60,460	825,965	-		-	OP Units
Omega Healthcare Investors...	C. Taylor Pickett	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	60,460	634,669	-		-	Profits Interest Units
Starwood Property Trust Inc	Barry S. Sternlicht	Director, CEO, Chairman of the Board	Other type of transaction at price $ 0.00 per share.	31 Mar 2025	59,676	2,820,764 (0%)	0%		0	Common Stock
Stagwell Inc - Ordinary Sh...	Jay Leveton	President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.93 per share.	31 Mar 2025	59,400	474,961	-	5.9	352,242	Class A Common Stock
Alto Ingredients Inc	Bryon T. McGregor	Director, President & CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.12 per share.	31 Mar 2025	58,929	930,836 (1%)	0%	1.1	66,000	Common Stock
Hallador Energy Co Board Meeting	Heath Aaron Lovell	President-Hallador Power	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	57,971	0	-		-	Restricted Stock Unit
Cipher Mining Inc	Tyler Page	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.30 per share.	31 Mar 2025	57,802	5,472,860	-	2.3	132,945	Common Stock
Lulus Fashion Lounge Holdi...	Mark Vos	President & CIO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.40 per share.	31 Mar 2025	57,563	1,294,776	-	0.4	23,025	Common Stock
Procore Technologies Inc	Lawrence Joseph Stack	Chief Revenue Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	57,500	218,868	-		0	Common Stock
ContextLogic Inc - Ordinar... Board Meeting	Jennifer Kwon Chou	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	56,701	56,701	-		-	Restricted Stock Unit
Hallador Energy Co Board Meeting	Brent K. Bilsland	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.28 per share.	31 Mar 2025	55,849	1,087,388 (3%)	0%	12.3	685,826	Common Stock
Alto Ingredients Inc	Robert R. Olander	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	55,500	280,556 (0%)	0%		0	Common Stock
Alto Ingredients Inc	Todd E. Benton	COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	55,500	189,112 (0%)	0%		0	Common Stock
AMMO Inc	Fred W. Wagenhals	Director, EXECUTIVE CHAIR		31 Mar 2025	55,000	7,334,449	-		0	Common Stock
Ardent Health Partners Inc Board Meeting	Alfred Lumsdaine	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	53,971	214,536	-		0	Common Stock
Hallador Energy Co Board Meeting	Brent K. Bilsland	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.28 per share.	31 Mar 2025	53,032	1,090,203 (3%)	0%	12.3	651,233	COMMON STOCK
Abercrombie & Fitch Co. - ... Board Meeting High Gain High Volume	Scott D. Lipesky	EVP and COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	52,296	163,734 (0%)	0%		0	Class A Common Stock
Ryerson Holding Corp.	Edward J. Lehner	Director, President & CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.96 per share.	31 Mar 2025	52,140	653,229 (1%)	0%	23.0	1,197,134	Common Stock (par value $0.01 per share)
Lululemon Athletica inc.	Calvin R. McDonald	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	51,315	51,315	-		-	Stock Option (right to buy)
Sarcos Technology and Robo...	Kristi Martindale	Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 5.82 per share.	31 Mar 2025	51,141	325,079	-	5.8	297,436	Common Stock
Organon & Co.	Joseph T. Morrissey	Head of Manufacturing	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	50,369	50,369	-		-	Restricted Stock Units
Anavex Life Sciences Corpo...	Athanasios Skarpelos	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	50,000	50,000	-		-	Stock Option (Right to Buy)
Anavex Life Sciences Corpo...	Steffen Thomas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	50,000	50,000	-		-	Stock Option (Right to Buy)
Anavex Life Sciences Corpo...	Peter Donhauser	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	50,000	50,000	-		-	Stock Option (Right to Buy)
Anavex Life Sciences Corpo...	Claus van der Velden	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	50,000	50,000	-		-	Stock Option (Right to Buy)
Anavex Life Sciences Corpo...	Jiong Ma	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	50,000	50,000	-		-	Stock Option (Right to Buy)
Cidara Therapeutics Inc	Shane M. Ward	COO & CLO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	50,000	50,000	-		-	Employee Stock Option (right to buy)
Corcept Therapeutics Inc	Joseph Douglas Lyon	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	50,000	50,000	-		-	Stock option (right to buy)
Corcept Therapeutics Inc	Joseph Douglas Lyon	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.26 per share.	31 Mar 2025	50,000	209,009 (0%)	0%	19.3	963,000	Common Stock
Carvana Co. - Ordinary Sha... 52 week high	Benjamin Huston	Chief Operating Officer		31 Mar 2025	50,000	173,803 (0%)	0%		0	Class A Common Stock
SharpLink Gaming Ltd 52 week high High Gain High Volume	Leslie Bernhard	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	50,000	50,000	-		-	Restricted Stock Units
SharpLink Gaming Ltd 52 week high High Gain High Volume	Robert M. Gutkowski	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	50,000	50,000	-		-	Restricted Stock Units
SharpLink Gaming Ltd 52 week high High Gain High Volume	Obie McKenzie	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	50,000	50,000	-		-	Restricted Stock Units
RAPT Therapeutics Inc Board Meeting High Loss High Volume	Wendye Robbins	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	49,432	49,432	-		-	Director Stock Option (right to buy)
Unisys Corp.	Peter A. Altabef	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.59 per share.	31 Mar 2025	49,183	1,354,866 (2%)	0%	4.6	225,750	Common Stock
Organon & Co.	Kevin Ali	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	48,758	97,518	-		-	Restricted Stock Units
Organon & Co.	Kevin Ali	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	48,758	248,677	-		0	Common Stock
Custom Truck One Source Inc	Marshall A. Heinberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	48,346	48,346	-		-	Restricted Stock Unit
Alto Ingredients Inc	James R Sneed	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	47,834	429,221 (0%)	0%		0	Common Stock
Alto Ingredients Inc	Auste M. Graham	CLO & Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	47,834	277,958 (0%)	0%		0	Common Stock
Sonim Technologies Inc	James S. Cassano	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	46,728	72,507 (0%)	0%		0	Common Stock
Sonim Technologies Inc	Michael C. Mulica	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	46,728	101,110 (0%)	0%		0	Common Stock
Sonim Technologies Inc	Jack Steenstra	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	46,728	72,520 (0%)	0%		0	Common Stock
Biodesix Inc	John Patience	Director, Chairman	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	46,686	384,612	-		-	Common Stock
Biodesix Inc	John Patience	Director, Chairman	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	46,686	0	-		-	Restricted Stock Units
Biodesix Inc	Charles Watts	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	46,686	421,705	-		-	Common Stock
Biodesix Inc	Charles Watts	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	46,686	0	-		-	Restricted Stock Units
TJX Companies, Inc.	Ernie L. Herrman	Director, CEO & President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	45,978	597,105 (0%)	0%		0	Common Stock
TJX Companies, Inc.	Douglas W. Mizzi	SEVP - Group President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	45,263	274,725 (0%)	0%		0	Common Stock
Ulta Beauty Inc Board Meeting	Kecia Steelman L.	President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	44,429	44,429	-		-	Stock Option (right to buy)
Unisys Corp.	Peter A. Altabef	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	44,248	1,371,708 (2%)	0%		0	Common Stock
TJX Companies, Inc.	Kenneth Canestrari	SEVP - Group President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	43,754	140,212 (0%)	0%		0	Common Stock
AMMO Inc	Jared R. Smith	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	43,333	479,807	-		0	Common Stock
Solid Power Inc - Ordinary...	John C. Van Scoter	Director, President & CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.08 per share.	31 Mar 2025	42,841	1,267,609	-	1.1	46,268	Common Stock
Nauticus Robotics Inc	Victoria Hay	Interim CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	42,798	42,798	-		-	Restricted Stock Units
Hallador Energy Co Board Meeting	Heath Aaron Lovell	President-Hallador Power	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	40,864	81,728	-		-	RSU
Abercrombie & Fitch Co. - ... Board Meeting High Gain High Volume	Samir Desai	EVP;Chief Digital&Tech Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	40,342	74,805 (0%)	0%		0	Class A Common Stock
Organon & Co.	Juan Camilo Arjona Ferreira	Head of R&D & CMO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	40,295	40,295	-		-	Restricted Stock Units
Organon & Co.	Kathryn DiMarco	Corporate Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	40,295	40,295	-		-	Restricted Stock Units
Corcept Therapeutics Inc	Joseph Douglas Lyon	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	40,000	0	-		-	Stock option (right to buy)
Corcept Therapeutics Inc	Joseph Douglas Lyon	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.82 per share.	31 Mar 2025	40,000	159,009 (0%)	0%	15.8	632,800	Common Stock
LifeMD Inc 52 week high	Maria Stan	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	40,000	167,500	-		0	Common Stock
LifeMD Inc 52 week high	Maria Stan	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	40,000	127,500	-		0	Common Stock
Custom Truck One Source Inc	Marshall A. Heinberg	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	39,993	352,202 (0%)	0%		0	Common Stock
Custom Truck One Source Inc	Marshall A. Heinberg	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	39,993	0	-		-	Restricted Stock Unit
Procore Technologies Inc	Benjamin C. Singer	Chief Legal Officer; Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	39,531	111,641	-		0	Common Stock
ON24 Inc	Sharat Sharan	Director, President and Chief Executive, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 5.23 per share.	31 Mar 2025	39,196	3,164,092	-	5.2	205,187	Common Stock
Organon & Co.	Kevin Ali	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	38,974	260,687	-		0	Common Stock
Organon & Co.	Kevin Ali	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	38,974	38,974	-		-	Restricted Stock Units
National Cinemedia Inc	Ronnie Y. Ng	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	38,750	0	-		-	Restricted Stock Units
National Cinemedia Inc	Ronnie Y. Ng	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	38,750	161,289 (0%)	0%		0	Common Stock
FrontView REIT Inc. Board Meeting	Timothy D. Dieffenbacher	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	37,286	37,286	-		-	Restricted Stock Units
Hillenbrand Inc	Kimberly K. Ryan	President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	37,102	37,102	-		-	Restricted Stock Units (Matching RSU Framework 03/31/2025)
Pyxis Oncology Inc	John L. Flavin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	36,979	36,979	-		-	Stock Option (Right to Buy)
Pyxis Oncology Inc	Freda C. Lewis-Hall	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	36,979	36,979	-		-	Stock Option (Right to Buy)
Pyxis Oncology Inc	Michael Metzger	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	36,979	36,979	-		-	Stock Option (Right to Buy)
Pyxis Oncology Inc	Rachel Humphrey	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	36,979	36,979	-		-	Stock Option (Right to Buy)
Pyxis Oncology Inc	Jakob Dupont	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	36,979	36,979	-		-	Stock Option (Right to Buy)
Pyxis Oncology Inc	Darren S. Cline	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	36,979	36,979	-		-	Stock Option (Right to Buy)
Pyxis Oncology Inc	Thomas Civik	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	36,979	36,979	-		-	Stock Option (Right to Buy)
Organon & Co.	Rachel A. Stahler	Chief Information Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	36,937	36,937	-		-	Restricted Stock Units
Organon & Co.	Kirke Weaver	Gen. Counsel & Corp. Secy.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	36,937	36,937	-		-	Restricted Stock Units
Hallador Energy Co Board Meeting	Heath Aaron Lovell	President-Hallador Power	Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.28 per share.	31 Mar 2025	36,915	129,952 (0%)	0%	12.3	453,316	COMMON STOCK
TJX Companies, Inc.	Carol Meyrowitz	Director, Executive Chairman	Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.80 per share.	31 Mar 2025	36,474	208,610 (0%)	0%	121.8	4,442,533	Common Stock
Ryerson Holding Corp.	Edward J. Lehner	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	36,300	36,300	-		-	Restricted Stock Units
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Jonathan Maurer	Co-Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	35,868	121,668	-		-	Class A common stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Jonathan Maurer	Co-Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	35,868	35,868	-		-	Restricted Stock Units
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Adam Comora	Co-Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	35,868	106,643	-		-	Class A common stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Adam Comora	Co-Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	35,868	35,868	-		-	Restricted Stock Units
Lyell Immunopharma Inc	Otis W. Brawley	Director	Purchase of securities on an exchange or from another person at price $ 0.56 per share.	31 Mar 2025	35,640	35,640	-	0.6	19,958	Common Stock
Hallador Energy Co Board Meeting	Heath Aaron Lovell	President-Hallador Power	Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.28 per share.	31 Mar 2025	35,482	131,385 (0%)	0%	12.3	435,719	COMMON STOCK
National Cinemedia Inc	Thomas F. Lesinski	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.84 per share.	31 Mar 2025	35,480	371,561 (0%)	0%	5.8	207,203	Common Stock
Corcept Therapeutics Inc	Joseph K. Belanoff	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 94.72 per share.	31 Mar 2025	35,102	2,982,335 (2%)	0%	94.7	3,324,861	Common Stock
Beam Therapeutics Inc	Giuseppe Ciaramella	President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	35,000	197,650 (0%)	0%		0	Common Stock
Corcept Therapeutics Inc	Joseph Douglas Lyon	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	35,000	56,571	-		-	Stock option (right to buy)
Corcept Therapeutics Inc	Joseph Douglas Lyon	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.56 per share.	31 Mar 2025	35,000	44,009 (0%)	0%	13.6	474,600	Common Stock
Liquidity Services Inc Board Meeting	Mateus-Tique Jaime	Director	Sale of securities on an exchange or to another person at price $ 30.71 per share.	31 Mar 2025	35,000	259,562 (0%)	0%	30.7	1,074,850	Common Stock
Turtle Beach Corp	Cristopher Keirn	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	34,176	34,176	-		-	Restricted Stock Units
Healthcare Triangle Inc 52 week low	Shibu Kizhakevilayil	Director, Head of M&A		31 Mar 2025	34,129	54,129	-		0	Common Stock
Cipher Mining Inc	Patrick Kelly	Co-President and COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	33,968	1,043,038	-		-	Common Stock
Cipher Mining Inc	Patrick Kelly	Co-President and COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	33,968	2,014,081	-		-	Restricted Stock Units
Cipher Mining Inc	William Iwaschuk	Co-President and CLO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	33,968	2,014,081	-		-	Restricted Stock Units
Cipher Mining Inc	William Iwaschuk	Co-President and CLO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	33,968	967,378	-		-	Common Stock
Commercial Vehicle Group Inc	Angela M. O’Leary	VP, Controller & Ch Acct Offcr	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	33,955	83,927 (0%)	0%		0	Common Stock, $0.01 par value
Palantir Technologies Inc ...	Ryan Taylor	See Remarks	Sale of securities on an exchange or to another person at price $ 83.44 per share.	31 Mar 2025	33,159	426,119	-	83.4	2,766,823	Class A Common Stock
Abbvie Inc	Jeffrey Ryan Stewart	EVP, CHIEF COMMERCIAL OFFICER	Sale of securities on an exchange or to another person at price $ 210.54 per share.	31 Mar 2025	33,132	53,234 (0%)	0%	210.5	6,975,611	Common Stock, $0.01 par value
Corcept Therapeutics Inc	Joseph Douglas Lyon	See Remarks	Sale of securities on an exchange or to another person at price $ 101.37 per share.	31 Mar 2025	32,942	14,059 (0%)	0%	101.4	3,339,416	Common Stock
Timken Co.	Richard Kyle	Director, Interim President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	32,400	32,400	-		-	Performance Based-Restricted Stock Units
GrafTech International Ltd.	Jean-Marc Germain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	31,609	102,761	-		-	Deferred Share Units
VYNE Therapeutics Inc	David Domzalski	Director, PRESIDENT AND CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.58 per share.	31 Mar 2025	30,498	445,563 (1%)	0%	1.6	48,187	Common Stock
Hallador Energy Co Board Meeting	Marjorie A. Hargrave	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.28 per share.	31 Mar 2025	30,267	30,267 (0%)	0%	12.3	371,679	Common Stock
Maiden Holdings Ltd High Gain High Volume	William T. Jarman	SVP & Chief Actuary	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	31 Mar 2025	30,092	208,249 (0%)	0%		0	Common Shares
LifeMD Inc 52 week high	Eric Yecies	Chief Legal Officer & GC	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	30,000	370,000	-		0	Common Stock
LifeMD Inc 52 week high	Stefan Galluppi	Chief Innovation Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	30,000	165,449	-		0	Common Stock
GrafTech International Ltd.	Sachin M. Shivaram	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	29,741	29,741	-		-	Deferred Share Units
Abercrombie & Fitch Co. - ... Board Meeting High Gain High Volume	Scott D. Lipesky	EVP and COO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.37 per share.	31 Mar 2025	29,210	134,524 (0%)	0%	76.4	2,230,768	Class A Common Stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	David Unger	Executive Vice President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.84 per share.	31 Mar 2025	29,093	108,933	-	1.8	53,531	Class A common stock
Aura Biosciences Inc	Teresa Marie Bitetti	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	29,000	29,000	-		-	Stock Option (Right to Buy)
Macy`s Inc Board Meeting	Antony Spring	Director, Chairman & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	28,588	57,176	-		-	Restricted Stock Units
Macy`s Inc Board Meeting	Antony Spring	Director, Chairman & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	28,588	349,832 (0%)	0%		0	Common Stock
Shoe Carnival, Inc. Board Meeting	Mark J. Worden	Director, PRESIDENT & CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.00 per share.	31 Mar 2025	28,412	283,261 (1%)	0%	22	625,064	Common Stock
Calumet Specialty Products...	Bruce Fleming	EVP - MONTANA RENEWABLES	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	28,320	28,320	-		-	Restricted Stock Unit
Origin Materials Inc	John Hickox	Director	Grant, award, or other acquisition of securities at price $ 0.66 per share.	31 Mar 2025	28,254	588,288	-	0.7	18,749	Common Stock
Full House Resorts, Inc.	Daniel R. Lee	Director, PRESIDENT & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	28,240	28,240	-		-	Employee Stock Option (right to buy)
Beam Therapeutics Inc	Amy Simon	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	27,500	96,305 (0%)	0%		0	Common Stock
Citizens, Inc. - Ordinary ...	Gerald W. Shields	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	27,472	0	-		-	Restricted Stock Units
Citizens, Inc. - Ordinary ...	Gerald W. Shields	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	27,472	27,472	-		-	Restricted Stock Units
Citizens, Inc. - Ordinary ...	Gerald W. Shields	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	27,472	303,942 (0%)	0%		-	Citizens, Inc. Class A Common Stock
Unisys Corp.	Peter A. Altabef	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.59 per share.	31 Mar 2025	27,406	1,327,460 (2%)	0%	4.6	125,794	Common Stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Betsy L. Battle	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	27,218	56,712	-		-	Class A common stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Betsy L. Battle	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	27,218	0	-		-	Restricted Stock Units
OPAL Fuels Inc - Ordinary ... High Gain High Volume	James J. Martell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	27,218	0	-		-	Restricted Stock Units
OPAL Fuels Inc - Ordinary ... High Gain High Volume	James J. Martell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	27,218	41,151	-		-	Class A common stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Ashok Vemuri	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	27,218	56,712	-		-	Class A common stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Ashok Vemuri	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	27,218	0	-		-	Restricted Stock Units
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Kevin M. Fogarty	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	27,218	56,712	-		-	Class A common stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Kevin M. Fogarty	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	27,218	0	-		-	Restricted Stock Units
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Scott Dols	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	27,218	56,712	-		-	Class A common stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Scott Dols	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	27,218	0	-		-	Restricted Stock Units
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Mark S. Comora	Director, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	27,218	56,712	-		-	Class A common stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Mark S. Comora	Director, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	27,218	0	-		-	Restricted Stock Units
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Nadeem Nisar	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	27,218	0	-		-	Restricted Stock Units
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Nadeem Nisar	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	27,218	86,712	-		-	Class A common stock
Jaguar Health Inc	James J. Bochnowski	Director	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	31 Mar 2025	27,002	27,002	-		-	Convertible Promissory Note
Jaguar Health Inc	James J. Bochnowski	Director	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	31 Mar 2025	27,002	27,002	-		-	Warrant to Purchase Common Stock
Ardent Health Partners Inc Board Meeting	David Schultz	President Hospital Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	26,985	64,172	-		0	Common Stock
Stagwell Inc - Ordinary Sh...	Frank P. Lanuto	Chief Financial Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	31 Mar 2025	26,974	661,276	-		0	Class A Common Stock
Organon & Co.	Kevin Ali	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.51 per share.	31 Mar 2025	26,964	221,713	-	14.5	391,248	Common Stock
Custom Truck One Source Inc	Georgia R. Nelson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	26,859	26,859	-		-	Restricted Stock Unit
Custom Truck One Source Inc	Mark D. Ein	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	26,859	26,859	-		-	Restricted Stock Unit
Custom Truck One Source Inc	Paul T. Bader	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	26,859	26,859	-		-	Restricted Stock Unit
Custom Truck One Source Inc	Mary M. Jackson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	26,859	26,859	-		-	Restricted Stock Unit
Omega Healthcare Investors...	Robert O. Stephenson	CHIEF FINANCIAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	26,659	492,432	-		-	OP Units
Omega Healthcare Investors...	Robert O. Stephenson	CHIEF FINANCIAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	26,659	238,994	-		-	Profits Interest Units
Lululemon Athletica inc.	Calvin R. McDonald	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	26,530	116,452 (0%)	0%		0	Common Stock
Lululemon Athletica inc.	Calvin R. McDonald	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	26,530	0	-		-	Performance Share Units
Stagwell Inc - Ordinary Sh...	Jay Leveton	President	Sale or transfer of securities back to the company at price $ 0.00 per share.	31 Mar 2025	26,075	534,361	-		0	Class A Common Stock
Occidental Petroleum Corp.	William R. Klesse	Director		31 Mar 2025	25,900	208,889 (0%)	0%	21.3	551,670	Common Stock
Occidental Petroleum Corp.	William R. Klesse	Director		31 Mar 2025	25,900	3,860	-		-	Warrants (Right to buy)
Lindblad Expeditions Holdi...	Natalya Leahy	CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	25,890	315,446 (0%)	0%		0	Common Stock
GrafTech International Ltd.	Anthony R. Taccone	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	25,862	168,911	-		-	Deferred Share Units
Omega Healthcare Investors...	Robert O. Stephenson	CHIEF FINANCIAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	25,738	265,653	-		-	Profits Interest Units
Omega Healthcare Investors...	Robert O. Stephenson	CHIEF FINANCIAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	25,738	465,773	-		-	OP Units
Abbvie Inc	Jeffrey Ryan Stewart	EVP, CHIEF COMMERCIAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	25,700	0	-		-	Option (Right to Buy)
Abbvie Inc	Jeffrey Ryan Stewart	EVP, CHIEF COMMERCIAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.02 per share.	31 Mar 2025	25,700	112,066 (0%)	0%	79.0	2,030,814	Common Stock, $0.01 par value
Abbvie Inc	Jeffrey Ryan Stewart	EVP, CHIEF COMMERCIAL OFFICER	Sale of securities on an exchange or to another person at price $ 209.49 per share.	31 Mar 2025	25,700	86,366 (0%)	0%	209.5	5,383,893	Common Stock, $0.01 par value
Organon & Co.	Vittorio Nisita	Head of Global Business Svcs	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	25,184	25,184	-		-	Restricted Stock Units
Abeona Therapeutics Inc	Vishwas Seshadri	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 4.78 per share.	31 Mar 2025	25,000	1,355,322 (1%)	0%	4.8	119,500	Common Stock
Kymera Therapeutics Inc	Bruce Jacobs	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	25,000	69,899	-		-	Stock Option (Right to Buy)
Kymera Therapeutics Inc	Bruce Jacobs	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share.	31 Mar 2025	25,000	226,886	-	2.1	52,000	Common Stock
Cidara Therapeutics Inc	Shane M. Ward	COO & CLO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	25,000	39,674 (0%)	0%		0	Common Stock
LifeMD Inc 52 week high	Dennis Wijnker	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	25,000	150,000	-		0	Common Stock
Lindblad Expeditions Holdi...	Noah Brodsky	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	25,000	79,590 (0%)	0%		0	Common Stock
AMMO Inc	Paul Joseph Kasowski	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	25,000	76,013	-		0	Common Stock
First Guaranty Bancshares Inc	Bruce McAnally	Director	Purchase of securities on an exchange or from another person at price $ 8.47 per share.	31 Mar 2025	24,615	145,839 (1%)	0%	8.5	208,489	COMMON STOCK
Origin Materials Inc	Craig A. Rogerson	Director	Grant, award, or other acquisition of securities at price $ 0.66 per share.	31 Mar 2025	24,487	289,511	-	0.7	16,250	Common Stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Jonathan Maurer	Co-Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.84 per share.	31 Mar 2025	24,227	151,716	-	1.8	44,578	Class A common stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	Adam Comora	Co-Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.84 per share.	31 Mar 2025	24,227	136,691	-	1.8	44,578	Class A common stock
Snap Inc - Ordinary Shares...	Michael J. O'Sullivan	General Counsel	Sale of securities on an exchange or to another person at price $ 8.60 per share.	31 Mar 2025	24,000	507,660 (0%)	0%	8.6	206,386	Class A Common Stock
Guardant Health Inc	Helmy Eltoukhy	Director, Co-Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	23,998	2,421,453 (2%)	0%		0	Common Stock
Guardant Health Inc	Helmy Eltoukhy	Director, Co-Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	23,998	167,980	-		-	Restricted Stock Units
Guardant Health Inc	AmirAli Talasaz	Director, Co-Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	23,998	167,980	-		-	Restricted Stock Units
Guardant Health Inc	AmirAli Talasaz	Director, Co-Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	23,998	2,321,619 (2%)	0%		0	Common Stock
Safehold Inc	Jay Sugarman	Director, CHAIRMAN AND CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	31 Mar 2025	23,926	1,804,622 (3%)	0%		0	Common Stock
Palantir Technologies Inc ...	Ryan Taylor	See Remarks	Sale of securities on an exchange or to another person at price $ 82.40 per share.	31 Mar 2025	23,913	459,278	-	82.4	1,970,496	Class A Common Stock
Frontdoor Inc.	Jessica P. Ross	SVP & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	23,666	23,666	-		-	Restricted Stock Units
Macy`s Inc Board Meeting	Adrian V. Mitchell	EVP, COO & CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	23,585	166,308 (0%)	0%		0	Common Stock
Macy`s Inc Board Meeting	Adrian V. Mitchell	EVP, COO & CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	23,585	47,170	-		-	Restricted Stock Units
OPAL Fuels Inc - Ordinary ... High Gain High Volume	David Unger	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	23,522	132,455	-		-	Class A common stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	David Unger	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	23,522	47,043	-		-	Restricted Stock Units
OPAL Fuels Inc - Ordinary ... High Gain High Volume	John Coghlin	General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	23,521	80,959	-		-	Class A common stock
OPAL Fuels Inc - Ordinary ... High Gain High Volume	John Coghlin	General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	23,521	208,335	-		-	Restricted Stock Units
Ryerson Holding Corp.	James J. Claussen	Executive Vice President & CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	23,450	94,454 (0%)	0%		0	Common Stock (par value $0.01 per share)
Dorian LPG Ltd Board Meeting	Oivind Lorentzen	Director	Sale of securities on an exchange or to another person at price $ 23.11 per share.	31 Mar 2025	23,386	48,933 (0%)	0%	23.1	540,450	Common Shares, $0.01 par value per share
Hallador Energy Co Board Meeting	Marjorie A. Hargrave	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	23,351	46,702	-		-	Restricted Stock Unit
Purple Innovation Inc - Or...	Robert T. DeMartini	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.76 per share.	31 Mar 2025	23,232	879,514 (4%)	0%	0.8	17,638	Class A Common Stock
Palantir Technologies Inc ...	Ryan Taylor	See Remarks	Sale of securities on an exchange or to another person at price $ 84.26 per share.	31 Mar 2025	22,948	403,171	-	84.3	1,933,507	Class A Common Stock
Alto Ingredients Inc	Auste M. Graham	CLO & Secretary	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.12 per share.	31 Mar 2025	22,677	255,281 (0%)	0%	1.1	25,398	Common Stock
Wolfspeed Inc	Thomas H. Werner	Director, Executive Chair, Chairman of the Board	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	22,500	241,335 (0%)	0%		0	COMMON STOCK
Ceco Environmental Corp.	Peter K. Johansson	See Remarks	Sale of securities on an exchange or to another person at price $ 22.80 per share.	31 Mar 2025	22,500	62,160 (0%)	0%	22.8	512,933	Common Stock
FrontView REIT Inc. Board Meeting	Drew Ireland	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	22,371	22,371	-		-	Restricted Stock Units
Ardent Health Partners Inc Board Meeting	Stephen C. Petrovich	EVP, GC and Asst. Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	22,263	719,091	-		0	Common Stock
Custom Truck One Source Inc	Georgia R. Nelson	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	22,218	105,804 (0%)	0%		0	Common Stock
Custom Truck One Source Inc	Georgia R. Nelson	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	22,218	0	-		-	Restricted Stock Unit
Custom Truck One Source Inc	Mark D. Ein	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	22,218	1,585,707 (3%)	0%		0	Common Stock
Custom Truck One Source Inc	Mark D. Ein	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	22,218	0	-		-	Restricted Stock Unit
Custom Truck One Source Inc	Paul T. Bader	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	22,218	93,804 (0%)	0%		0	Common Stock
Custom Truck One Source Inc	Paul T. Bader	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	22,218	0	-		-	Restricted Stock Unit
Custom Truck One Source Inc	Mary M. Jackson	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	22,218	55,173 (0%)	0%		0	Common Stock
Custom Truck One Source Inc	Mary M. Jackson	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	22,218	0	-		-	Restricted Stock Unit
Alto Ingredients Inc	Robert R. Olander	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.12 per share.	31 Mar 2025	22,128	258,428 (0%)	0%	1.1	24,783	Common Stock
Clearwater Analytics Holdi...	Sandeep Sahai	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	21,991	886,672	-		0	Class A Common Stock
Clearwater Analytics Holdi...	Sandeep Sahai	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	21,991	329,861	-		-	Restricted Stock Unit
TJX Companies, Inc.	Douglas W. Mizzi	SEVP - Group President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.80 per share.	31 Mar 2025	21,885	252,840 (0%)	0%	121.8	2,665,593	Common Stock
Credo Technology Group Hol... Board Meeting	Chi Fung Cheng	Director, Chief Technology Officer	Sale of securities on an exchange or to another person at price $ 40.04 per share.	31 Mar 2025	21,574	7,993,602	-	40.0	863,896	Ordinary Shares
Organon & Co.	Kevin Ali	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.51 per share.	31 Mar 2025	21,553	239,134	-	14.5	312,734	Common Stock
Amylyx Pharmaceuticals Inc	Joshua Cohen	Director, Co-Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 3.47 per share.	31 Mar 2025	21,490	3,355,280	-	3.5	74,482	Common Stock
Amylyx Pharmaceuticals Inc	Justin Klee	Director, Co-Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 3.46 per share.	31 Mar 2025	21,490	3,355,276	-	3.5	74,454	Common Stock
Organon & Co.	Kevin Ali	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	21,472	0	-		-	Restricted Stock Units
Organon & Co.	Kevin Ali	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	21,472	260,606	-		0	Common Stock
Universal Technical Instit...	Adrienne DeTray	SVP and CIO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	21,242	21,242 (0%)	0%		0	Common Stock, $0.0001 par value
Core & Main Inc - Ordinary...	Robyn Bradbury	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	21,192	21,192	-		-	Options (Rights to Buy)
TJX Companies, Inc.	Kenneth Canestrari	SEVP - Group President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.80 per share.	31 Mar 2025	21,156	119,056 (0%)	0%	121.8	2,576,801	Common Stock
Purple Innovation Inc - Or...	Eric S. Haynor	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	21,101	42,202	-		-	Restricted Stock Units
Purple Innovation Inc - Or...	Eric S. Haynor	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	21,101	213,034 (1%)	0%		-	Class A Common Stock
Aura Biosciences Inc	Teresa Marie Bitetti	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	21,000	21,000	-		0	Common Stock
Ardent Health Partners Inc Board Meeting	Ethan Chernin	President of Health Services	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	20,914	35,988	-		0	Common Stock
PPL Corp	David J. Bonenberger	EVP & COO-Utilities	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	20,770	20,770	-		-	Stock Unit (SIP)
Lulus Fashion Lounge Holdi...	Dara Bazzano	Director, Board Chair	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	20,694	148,732	-		0	Common Stock
Lindblad Expeditions Holdi...	Frederick Goldberg	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	20,496	70,496 (0%)	0%		0	Common Stock
Stagwell Inc - Ordinary Sh...	Ryan Greene	Chief Operating Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.93 per share.	31 Mar 2025	20,395	190,597	-	5.9	120,942	Class A Common Stock
Hillenbrand Inc	Robert M. VanHimbergen	Sr. VP, CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	20,239	20,239	-		-	Restricted Stock Units (Matching RSU Framework 03/31/2025)
Organon & Co.	Daniel Karp	Executive VP, Corp. Dev.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	20,147	20,147	-		-	Restricted Stock Units
Abercrombie & Fitch Co. - ... Board Meeting High Gain High Volume	Samir Desai	EVP;Chief Digital&Tech Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.37 per share.	31 Mar 2025	20,001	54,804 (0%)	0%	76.4	1,527,476	Class A Common Stock
McCormick & Co., Inc. - Or...	Jeffery D. Schwartz	Vice President, Gen Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.96 per share.	31 Mar 2025	20,000	89,958 (0%)	0%	50.0	999,200	Common Stock - Voting
McCormick & Co., Inc. - Or...	Jeffery D. Schwartz	Vice President, Gen Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2025	20,000	20,000	-		-	Options - Right to Buy
Lesaka Technologies Inc	Ali Haeri Mazanderani	Director, Executive Chairman	Purchase of securities on an exchange or from another person at price $ 4.96 per share.	31 Mar 2025	20,000	525,115 (0%)	0%	5.0	99,200	Common Stock
Beam Therapeutics Inc	Christine Bellon	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	20,000	122,968 (0%)	0%		0	Common Stock
LifeMD Inc 52 week high	Maria Stan	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	20,000	187,500	-		0	Common Stock
LifeMD Inc 52 week high	Maria Stan	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	20,000	207,500	-		0	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.

US Stocks - Insider Trading disclosures made made on Mar 31, 2025

View 400 US Stocks - Insider Trading disclosures made on US Exchanges on Mar 31, 2025.

The latest disclosure under SEC insider trading regulations was reported by Stagwell Inc - Ordinary Shares - Class A., where the revocation of 151,648,741 Class A Common Stock of common stock was executed . This transaction was reported to the Securities and Exchange Commission on March 31, 2025.

Screeners based on Insider Trading parameters